- Home
- JYD
as 07-26-2024 4:00pm EST
Jayud Global Logistics Ltd is a end-to-end supply chain solution providers in China, with a focus on providing cross-border logistics services. It offers freight forwarding services, (ii) supply chain management, and (iii) other value-added services.
| Founded: | 2001 | Country: | China |
| Employees: | N/A | City: | N/A |
| Market Cap: | 12.6M | IPO Year: | 2023 |
| Target Price: | N/A | AVG Volume (30 days): | 48.4K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.48 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.42 - $3.55 | Next Earning Date: | 08-30-2024 |
| Revenue: | $70,221,185 | Revenue Growth: | 71.48% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Jayud Global Logistics Limited News
JYD Breaking Stock News: Dive into JYD Ticker-Specific Updates for Smart Investing
MT Newswires
3 days ago
Jayud Global Logistics Signs Deal With Lazbao to Expand Southeast Asian Air Service Network
GlobeNewswire
4 days ago
Jayud Global Logistics Partners with Leading Southeast Asian E-commerce Provider Lazbao Group
Yahoo Finance Video
2 months ago
FDA panel votes to recommend Eli Lilly's Alzheimer's drug
GlobeNewswire
2 months ago
Chu Vision Institute Unveils Comprehensive Guide to LASIK Recovery and Aftercare, Pioneering Patient Care in Minneapolis
Reuters
2 months ago
California seeks company profits in Big Oil climate lawsuit
USA TODAY
2 months ago
S&P 500, Nasdaq post record closing highs; Fed meeting, CPI ahead
GlobeNewswire
2 months ago
Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis
Business Wire
2 months ago
Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock
Compare JYD vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "JYD Jayud Global Logistics Limited - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.